#
Report: Molecular Markers of FSHD
May 3, 2025
Updates on Aim 1 & 2 during year 2.
#
Report: The role of macrophages in Facioscapulohumeral muscular dystrophy
Apr 27, 2025
First year report.
#
Report: Mapping Facioscapulohumeral muscular dystrophy through single nuclei RNA sequencing
Apr 10, 2025
Year one report on progress.
#
Update: Understanding Global Genetic Diversity in FSHD and Building International Trial Readiness
Mar 19, 2025
Final project report on global genetic diversity.
#
Update: FSHD Blood Biomarker Development
Jan 27, 2025
Initial update on grant progress.
#
Update: Consequence of human satellite II repeat expression in FSHD
Jan 27, 2025
Final grant report.
#
Update: Validation of extracellular vesicle-associated circulating biomarkers for FSHD in cross-sectional and longitudinal clinical studies
Jan 27, 2025
Initial update on grant.
#
Update: Exploring the interaction between mitochondrial dynamics and autophagy: can we counteract accumulation of dysfunctional mitochondria in FSHD muscle?
Jan 9, 2025
Year 1 summary of progress.
#
Update: Generating a 3D spatially patterned FSHD tissue construct for disease modeling and therapeutic strategies using suspended tissue open microfluidic patterning (STOMP)
Jan 7, 2025
Initial update on grant.
#
Update: Collaborative Effort to Evaluate a Novel Treatment Paradigm for FSHD Using EB-ON Technology
Jan 6, 2025
Part I of the collaborative project.
#
Update: A silencing reporter system to discover factors and pathways implicated in D4Z4 repression in Facioscapulohumeral dystrophy
Jan 4, 2025
#
Update: TF-Scan Pilot Study
Dec 10, 2024
Summary of the results of the Talus pilot project and their potential impact.
#
Behind the Scenes - Tapscott Lab
Nov 18, 2024
Behind the scenes at the Tapscott Lab at the Fred Hutchinson Cancer Center in Seattle.
#
Update: Uncovering the genetic drivers and suppressors of DUX4 in FSHD
Nov 15, 2024
Final grant report.
#
Report: The role of macrophages in Facioscapulohumeral muscular dystrophy
Nov 8, 2024
Dr. Nunes' initial project report.
#
Report: Mapping Facioscapulohumeral muscular dystrophy through single nuclei RNA sequencing
Nov 6, 2024
Initial progress report.
#
Report: Molecular Markers of FSHD
Nov 2, 2024
The mid-year progress report for Dr. Stephen Tapscott’s project.
#
Update: Motor Outcomes to Validate Evaluations in FSHD
Aug 4, 2024
MOVE FSHD study update.
#
Progress Update: Flex fund for clinical study participant reimbursement
Jul 11, 2024
Patient study update by Dr. Kyba after a Covid hiatus.
#
Progress Update: Consequence of human satellite II repeat expression in FSHD
Jun 27, 2024
Findings indicate selective interactions of RNA binding proteins with HSATII RNA, which may impact mRNA processing pathways downstream of DUX4 expression; and that HSATII RNA structure dictates protein recruitment.